Lyte
Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.
$165MSeries C
ParticipantKC
Key1 Capital
Activity from announced rounds
Activity in this selectionOct 28, 2026 · Jul 31, 2026
Key1 Capital is an Israeli growth-technology manager whose investment records identify Lyte, Remepy and Xsight.
Recorded funding activity
Lyte develops robotic perception systems. Remepy combines prescription medicines with therapeutic software, while Xsight designs connectivity chips for computing infrastructure. The companies pursue distinct hardware and healthcare products.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 1 First participation on record · 1 follow-on
- Funding in participating rounds
- $201M 2 disclosed · full round size, not this investor’s share